HomeCompareFUSIX vs JNJ

FUSIX vs JNJ: Dividend Comparison 2026

FUSIX yields 2.99% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FUSIX wins by $4.2K in total portfolio value
10 years
FUSIX
FUSIX
● Live price
2.99%
Share price
$15.17
Annual div
$0.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.2K
Annual income
$362.93
Full FUSIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FUSIX vs JNJ

📍 FUSIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFUSIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FUSIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FUSIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FUSIX
Annual income on $10K today (after 15% tax)
$254.38/yr
After 10yr DRIP, annual income (after tax)
$308.49/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $395.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FUSIX + JNJ for your $10,000?

FUSIX: 50%JNJ: 50%
100% JNJ50/50100% FUSIX
Portfolio after 10yr
$22.1K
Annual income
$595.35/yr
Blended yield
2.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FUSIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FUSIX buys
0
JNJ buys
0
No recent congressional trades found for FUSIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFUSIXJNJ
Forward yield2.99%3.36%
Annual dividend / share$0.45$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.2K$20.0K
Annual income after 10y$362.93$827.78
Total dividends collected$3.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FUSIX vs JNJ ($10,000, DRIP)

YearFUSIX PortfolioFUSIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,999$299.27$10,676$355.77+$323.00FUSIX
2$12,077$307.65$11,407$389.39+$670.00FUSIX
3$13,238$315.69$12,198$426.53+$1.0KFUSIX
4$14,488$323.40$13,056$467.62+$1.4KFUSIX
5$15,833$330.78$13,987$513.12+$1.8KFUSIX
6$17,279$337.84$14,998$563.56+$2.3KFUSIX
7$18,833$344.58$16,098$619.52+$2.7KFUSIX
8$20,503$351.00$17,295$681.69+$3.2KFUSIX
9$22,295$357.11$18,599$750.82+$3.7KFUSIX
10$24,218$362.93$20,022$827.78+$4.2KFUSIX

FUSIX vs JNJ: Complete Analysis 2026

FUSIXStock

The fund invests primarily in non-U.S. securities, including securities of issuers located in emerging markets. It invests primarily in common stocks. It invests directly in securities through one or more managers (sub-advisers) or indirectly in securities through one or more other funds, referred to as underlying funds, which in turn invest directly in securities. The fund allocates assets among underlying Fidelity® international funds (underlying funds) and sub-advisers.

Full FUSIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FUSIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FUSIX vs SCHDFUSIX vs JEPIFUSIX vs OFUSIX vs KOFUSIX vs MAINFUSIX vs ABBVFUSIX vs MRKFUSIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.